251 related articles for article (PubMed ID: 12356842)
1. Platelet-activating factor in vasoobliteration of oxygen-induced retinopathy.
Beauchamp MH; Marrache AM; Hou X; Gobeil F; Bernier SG; Lachapelle P; Abran D; Quiniou C; Brault S; Peri KG; Roberts J; Almazan G; Varma DR; Chemtob S
Invest Ophthalmol Vis Sci; 2002 Oct; 43(10):3327-37. PubMed ID: 12356842
[TBL] [Abstract][Full Text] [Related]
2. Redox-dependent effects of nitric oxide on microvascular integrity in oxygen-induced retinopathy.
Beauchamp MH; Sennlaub F; Speranza G; Gobeil F; Checchin D; Kermorvant-Duchemin E; Abran D; Hardy P; Lachapelle P; Varma DR; Chemtob S
Free Radic Biol Med; 2004 Dec; 37(11):1885-94. PubMed ID: 15528047
[TBL] [Abstract][Full Text] [Related]
3. Dominant role for calpain in thromboxane-induced neuromicrovascular endothelial cytotoxicity.
Quiniou C; Sennlaub F; Beauchamp MH; Checchin D; Lahaie I; Brault S; Gobeil F; Sirinyan M; Kooli A; Hardy P; Pshezhetsky A; Chemtob S
J Pharmacol Exp Ther; 2006 Feb; 316(2):618-27. PubMed ID: 16214879
[TBL] [Abstract][Full Text] [Related]
4. Role of thromboxane in retinal microvascular degeneration in oxygen-induced retinopathy.
Beauchamp MH; Martinez-Bermudez AK; Gobeil F; Marrache AM; Hou X; Speranza G; Abran D; Quiniou C; Lachapelle P; Roberts J; Almazan G; Varma DR; Chemtob S
J Appl Physiol (1985); 2001 Jun; 90(6):2279-88. PubMed ID: 11356793
[TBL] [Abstract][Full Text] [Related]
5. Biological effects of the new platelet-activating factor receptor antagonist (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride.
Imanishi N; Murakami-Uchida M; Koike H; Natsume Y; Morooka S
Arzneimittelforschung; 1994 Mar; 44(3):317-22. PubMed ID: 8192697
[TBL] [Abstract][Full Text] [Related]
6. Biochemical and pharmacological properties of SR 27388, a dual antioxidant and PAF receptor antagonist.
Herbert JM; Fraisse L; Bachy A; Valette G; Savi P; Laplace MC; Lassalle J; Roche B; Lale A; Keane PE
J Lipid Mediat; 1993 Aug; 8(1):31-51. PubMed ID: 8257776
[TBL] [Abstract][Full Text] [Related]
7. Strain-dependent differences in oxygen-induced retinopathy in the inbred rat.
van Wijngaarden P; Coster DJ; Brereton HM; Gibbins IL; Williams KA
Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1445-52. PubMed ID: 15790914
[TBL] [Abstract][Full Text] [Related]
8. Herbimycin A inhibits angiogenic activity in endothelial cells and reduces neovascularization in a rat model of retinopathy of prematurity.
McCollum GW; Rajaratnam VS; Bullard LE; Yang R; Penn JS
Exp Eye Res; 2004 May; 78(5):987-95. PubMed ID: 15051479
[TBL] [Abstract][Full Text] [Related]
9. Equine peritoneal macrophage production of thromboxane and prostacyclin in response to platelet activating factor and its receptor antagonist SRI 63-441.
Morris DD; Moore JN
Circ Shock; 1989 Jun; 28(2):149-58. PubMed ID: 2544315
[TBL] [Abstract][Full Text] [Related]
10. Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia.
Kern TS; Tang J; Mizutani M; Kowluru RA; Nagaraj RH; Romeo G; Podesta F; Lorenzi M
Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):3972-8. PubMed ID: 11053301
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological characterization of a receptor for platelet-activating factor on guinea pig peritoneal macrophages using [3H]apafant, a selective and competitive platelet-activating factor antagonist: evidence that the noncompetitive behavior of apafant in functional studies relates to slow kinetics of dissociation.
Ring PC; Seldon PM; Barnes PJ; Giembycz MA
Mol Pharmacol; 1993 Feb; 43(2):302-12. PubMed ID: 8381515
[TBL] [Abstract][Full Text] [Related]
12. Receptor-mediated and protein kinase-dependent growth enhancement of primary human fibroblasts by platelet activating factor.
Bennett SA; Birnboim HC
Mol Carcinog; 1997 Dec; 20(4):366-75. PubMed ID: 9433481
[TBL] [Abstract][Full Text] [Related]
13. Synergistic effect of platelet-activating factor and tumor necrosis factor-alpha on corneal myofibroblast apoptosis.
He J; Bazan HE
Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):883-91. PubMed ID: 16505020
[TBL] [Abstract][Full Text] [Related]
14. [Involvement of PAF (Platelet-Activating Factor) in chloroquine-induced retinopathy].
Meyniel G; Doly M; Millerin M; Braquet P
C R Acad Sci III; 1992; 314(2):61-5. PubMed ID: 1559183
[TBL] [Abstract][Full Text] [Related]
15. Platelet-activating factor (PAF) mediation of rat anaphylactic responses to soluble immune complexes. Studies with PAF receptor antagonist L-652,731.
Doebber TW; Wu MS; Biftu T
J Immunol; 1986 Jun; 136(12):4659-68. PubMed ID: 3011900
[TBL] [Abstract][Full Text] [Related]
16. Blood-brain barrier breakdown by PAF and protection by XQ-1H due to antagonism of PAF effects.
Deng Y; Fang W; Li Y; Cen J; Fang F; Lv P; Gong S; Mao L
Eur J Pharmacol; 2009 Aug; 616(1-3):43-7. PubMed ID: 19555682
[TBL] [Abstract][Full Text] [Related]
17. KIOM-79 prevents methyglyoxal-induced retinal pericyte apoptosis in vitro and in vivo.
Kim OS; Kim J; Kim CS; Kim NH; Kim JS
J Ethnopharmacol; 2010 Jun; 129(3):285-92. PubMed ID: 20362656
[TBL] [Abstract][Full Text] [Related]
18. Cell death in rat cerebellar granule neurons induced by hydrogen peroxide in vitro: mechanisms and protection by adenosine receptor ligands.
Fatokun AA; Stone TW; Smith RA
Brain Res; 2007 Feb; 1132(1):193-202. PubMed ID: 17188658
[TBL] [Abstract][Full Text] [Related]
19. Effects of platelet-activating factor, thromboxane A2 and leukotriene D4 on isolated perfused rat liver.
Cui S; Shibamoto T; Liu W; Takano H; Kurata Y
Prostaglandins Other Lipid Mediat; 2006 Jul; 80(1-2):35-45. PubMed ID: 16846785
[TBL] [Abstract][Full Text] [Related]
20. Antioxidant superoxide dismutase attenuates increased endothelial permeability induced by platelet-activating factor.
Zhang Y; Gu Y; Lucas MJ; Wang Y
J Soc Gynecol Investig; 2003 Jan; 10(1):5-10. PubMed ID: 12517587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
